Key result
Anticoagulation therapy options and optimal duration for venous thromboembolism are reviewed, comparing newer agents to traditional treatments based on recent studies and guidelines.
Why the study?
Data remain sparse regarding primary and secondary VTE prevention as well as the optimal duration of anticoagulation therapy.
This review discusses the role of factor Xa in the coagulation cascade and compares newer anticoagulation agents to traditional treatments for VTE based on recent guidelines.
Answers are grounded in this paper and cite their sources.
Review highlights gaps in VTE molecular mechanisms and therapy data; leaves open targeted research beyond anticoagulation.
Venous thromboembolism (VTE), clinically presented as deep-vein thrombosis (DVT) or pulmonary embolism (PE), constitutes a major global healthcare concern with severe complications, long-term morbidity, and mortality. Although several clinical, genetic, and acquired risk factors for VTE have been identified, the molecular pathophysiology and mechanisms of disease progression remain poorly understood. Anticoagulation has been the cornerstone of therapy for decades, but data is sparse regarding primary and secondary VTE prevention, as well as optimal therapy duration. In this review, we discuss the role of factor Xa in the coagulation cascade and the different choices of anticoagulation therapy based on patients' predisposing risk factors and risk of event recurrence. Further, we compare newer agents to traditional anticoagulation treatment based on the most recent studies and guidelines.
No takes yet. Share an insight, caveat, or question.
Diavati et al. (2021) conducted a review in Venous thromboembolism (VTE). Anticoagulation therapy vs. Traditional anticoagulation treatment was evaluated. Anticoagulation therapy options and optimal duration for venous thromboembolism are reviewed, comparing newer agents to traditional treatments based on recent studies and guidelines.
Synapse has enriched 10 related papers. Consider them for comparative context: